Sungwoo Hong
Papers
2
Total Citations
48
H-Index
2
About
Dr. Sungwoo Hong is a leading urologic surgeon whose research focuses on optimizing surgical outcomes for prostate cancer patients, particularly through comparative effectiveness studies and enhanced recovery protocols. His major contributions center on refining perioperative care in robot-assisted laparoscopic prostatectomy (RALP) and radical retropubic prostatectomy (RRP). In a pivotal prospective randomized controlled trial (2013, 25 citations), Dr. Hong demonstrated that tamsulosin significantly reduces acute urinary retention following early catheter removal after RALP—a finding that directly improved patient comfort and shortened recovery. His comparative study of RRP versus RALP (2013, 23 citations) provided critical evidence on postoperative complication profiles, helping surgeons and patients make informed treatment decisions. By systematically evaluating surgical techniques and pharmacological interventions, Dr. Hong has advanced the evidence base for prostate cancer surgery, influencing clinical guidelines and reducing morbidity. His work exemplifies how rigorous clinical research can translate into tangible improvements in patient care, making him a respected voice in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2